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Do Quality of Life (QOL) Index Scores Truly Reflect the Degree of
Clinical Improvement Following Intervention in Patients With Inter-
mittent Claudication due to Femoro-Popliteal Disease? Results of an
Observational Study
Fayyaz A K Mazari, Mohd N A Abdul Rahman, Tapan Mehta, Peter
McCollum, Ian C Chetter. Academic Vascular Surgery Unit, University of
Hull, Hull, United Kingdom
Objectives:To establish the relationship between quality of life (QOL)
index scores and clinical indicators of lower limbs ischaemia.
Methods: 178 patients (108 men, median age 70 years) with angio-
plastiable femoro-popliteal were recruited. Assessments were done prior to
and at 1, 3 6 and 12 months following intervention(angioplasty and / or
supervised exercise programme). Clinical indicators of lower limb ischaemia
(treadmill walking distances, ankle pressures), generic (SF36, EuroQol) and
disease specific (Kings College VascuQol) quality of life questionnaires were
analysed. Correlation analysis was performed for index scores as well as
individual domain scores using non-parametric tests.
Results: All clinical indicators of lower limb ischaemia and quality of life
index scores showed a statistically significant improvement as result of interven-
tion (Friedman test, p0.005). All generic QOL index scores (SF36, Euro-
Qol) showed moderate but statistically significant correlation with treadmill
walking distances (Spearman rank correlation, r0.523, p 0.005) and
weak but significant correlation to resting ankle brachial pressure index
(r0.153, p0.005). No significant correlation was seen between post
exercise ABPI and generic QOL index scores (r0.033, p0.547). Disease
specific QOL index scores showed similar moderate correlation to the
treadmill walking distances (r0.584, p0.005) and a weak but statistically
significant correlation with resting and post exercise ABPI (r0.378, p 
0.05). All domains of SF36 showed similar results with strongest correlation
seen in the domains of physical function (r 0.538, p0.005) and bodily
pain (r0.524, p0.005).
Conclusion: All generic and disease specific QOL scores show statis-
tically significant improvement with intervention in patients with femoro-
popliteal claudication. However, the degree of improvement seen in clinical
indicators of lower limb ischaemia shows a weak correlation to these scores-
.Therefore, a combination of clinical and QOL indicators should be used to
report outcome for intervention studies in these patients.
Author Disclosures: F.A.K. Mazari, None; M.N.A. Abdul Rahman,
None; T. Mehta, None; P. McCollum, None; I.C. Chetter, None.
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Office-Based Outpatient Angiosuites: A Paradigm for a Safe, Effective,
and Efficient Endovascular Practice
Samuel SAhn1, Julia FChen1,2, KennethRKollmeyer2, Rhoda FLeichter1, Todd
Reil1, Craig Ferrera2, Pablo Uceda2, Christopher Kim1, Kevin Peng1. 1University
Vascular Associates, Los Angeles, CA; 2DFWVascular Group, Dallas, TX
Purpose: To demonstrate that therapeutic and diagnostic endovascu-
lar procedures, traditionally performed in an outpatient hospital setting, can
be done with equal or better safety, efficacy and efficiency in an office setting.
Method: From April 25, 2006 to October 31, 2008, we performed
422 endovascular procedures in our office-based outpatient angiosuite. This
represents 28.3% of total patients who underwent endovascular procedures
in both the hospital and office. There were 213 (50.47%) men and 209
(49.52%) women, with an average age of 60.85 years (range: 17 to 93; SD:
15.89 years). Risk factors included arrhythmia (n21, 4.98%), coronary
artery disease (n108, 25.59%), congestive heart failure (n24, 5.69%),
diabetes (n165, 39.10%), dialysis (n78, 18.48%), hyperlipidemia (n94,
(22.27%), hypertension (n272, 64.45%), COPD (n23, 5.45%), TIA/
CVA (n23, 5.45%), and history ofMI (n47, 11.14%). ASA classifications
were I (n34, 8.05%), II (n73, 17.30%), III (n238, 56.40%), and IV
(n60, 14.22%), with 17 (4.03%) unavailable.
Results: We performed 134 (31.75%) diagnostic angiograms, 204
(48.34%) balloon angioplasties, 72 (17.06%) angioplasties with stent place-
ments, and 6 (1.42%) coil embolizations. All procedures were performed
under local anesthesia with anesthesia standby. The planned procedures
were completed in 97.87% (n413) patients. The complication rate was
2.13% (n9). Of these, 6 were electively admitted (2 thromboemboli, 2
hematomas, 1 malignant hypertension, 1 neuroangio edema) and 1 required
emergency transfer. The reason for transfer was a torn common femoral vein
upon attempted retrieval of a migrated stent. 30-day mortality was 0.46%
(n2), both unrelated to the procedures.
Conclusion: With careful patient selection and technique, therapeutic
and diagnostic endovascular procedures can be safely, effectively, and effi-
ciently performed in an office setting.Author Disclosures: S.S. Ahn, Vascular Management Associates; J.F.
Chen, Vascular Management Associates; K.R. Kollmeyer, None; R.F.
Leichter, None; T. Reil, None; C. Ferrera, None; P. Uceda, None; C.
Kim, None; K. Peng, Vascular Management Associates.
PP95.
Factors Associated with Aspirin-Insensitive Thromboxane Generation
in Patients with Atherosclerosis
Susanna M Nazarian1, Jason B Thompson1, Tyler J Gluckman1, Katherine
Laws1, F Jon Geske2, Steven P Schulman1, Thomas S Kickler1, Jeffrey J
Rade1. 1Johns Hopkins University, Baltimore, MD; 2Corgenix Medical
Corporation, Broomfield, CO
Objective: Measurement of the thromboxane A2 metabolite, 11-
dehydro-thromboxane B2 (TXB2), is used to assess response to aspirin
therapy and to define patients who are “aspirin resistant.” Little is known
about factors that may contribute to persistent TXB2 generation in spite of
adequate suppression of platelet COX-1 activity by aspirin.
Methods: 284 subjects with confirmed inhibition of arachidonic acid
(AA)-induced platelet aggregation by chronic aspirin therapy were tested for
urine TXB2. All patients had undergone CABG 6 months previous. Simul-
taneous hematologic (complete blood count, reticulated platelet count,
ABO blood group,) inflammatory (C-reactive protein, fibrinogen, von
Willebrand factor) and oxidative stress measurements (urine 8-iso prosta-
glandin F2) were performed. Demographic, medical history and pharma-
cological factors were also considered. A multivariate model was created to
predict odds of urinary TXB2 400 pg/mg creatinine (Cr).
Results: Despite complete inhibition of AA-induced platelet aggrega-
tion, 95/284 (33.5%) subjects had TXB2  400 pg/mg Cr. Multivariate
analysis identified several factors associated with odds of high TXB2, shown
below in descending order of strength of evidence:
Predictor for urinary TXB2400 pg/mg creatinine Odds ratio P value
Urine 8-iso-prostaglandin F2alpha ( 1072 vs. 
1072 pg/mg creatinine)
3.73 0.000
Race (white vs. non-white) 0.16 0.001
Beta-blocker use 0.28 0.005
Leukocyte count ( 4.5 vs. 4.5 - 11  103/cubic
mm)
0.13 0.008
Gender (female vs. male) 2.66 0.017
History of congestive heart failure 2.98 0.021
Age (per additional year) 1.04 0.027
von Willebrand factor antigen ( 150 vs.  150%) 2.12 0.034
Aspirin dose (325 mg vs. 81 mg) 0.34 0.045
Leukocyte count ( 11 vs. 4.5 - 11  103/cubic
mm)
4.04 0.346
Conclusions: Persistent thromboxane generation occurs in a substan-
tial percentage of patients 6 months after surgery despite suppression of
platelet COX-1 activity by aspirin. Non-white race, female gender, advanced
age and heart failure appear to be important patient-specific factors associ-
ated with increased aspirin-insensitive thromboxane generation. In addition,
elevated urine thromboxane levels were significantly associated with beta-
blocker use and degree of oxidative stress and inflammation. These latter
findings suggest that metabolism of arachidonic acid via non-enzymatic
and/or COX-2-mediated pathways may be important contributors to aspi-
rin-insensitive thromboxane generation.
Author Disclosures: S.M. Nazarian, None; J.B. Thompson, None; T.J.
Gluckman, None; K. Laws, None; F.J. Geske, Corgenix Medical Corpo-
ration; S.P. Schulman, None; T.S. Kickler, Corgenix Medical Corpora-
tion; J.J. Rade, Corgenix Medical Corporation.
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Patterns of Procedure Specific Radiation Exposure in the Endovascular
Era: Impetus for Further Innovation
Mohsen Bannazadeh1, Timur P Sarac1, Ozcan Altinel2, Vikram Kashyap1,
Daniel Clair1. 1The Cleveland Clinic Foundation, Cleveland, OH; 2Univer-
sity of Ankara Turkey, Cleveland, OH
Objective: While patient preference and outcome data support contin-
ued development and utilization of minimally invasive endovascular thera-
pies, only a few studies have documented radiation exposure to the patient.
This report summarizes our patient’s radiation exposure per endovascular
procedure.
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procedures done at our institution over an 18 month period. Radiation
exposure was categorized per procedures. Estimated Skin Dose (ESD)
(mGy) and Effective Dose (mSv) were calculated. Also, total CT scans were
tabulated for patients undergoing aneurysm stent grafting and cumulative
ED was estimated. Statistical analyses were done with Kruskal-Wallis tests to
detect overall differences, Wilcoxon Rank Sum Exact tests for paired com-
parisons, and for group comparisons a Bonferroni post hoc test.
Results: 2103 interventions in 1111 patients had fluoroscopy times
recorded during this period. As expected, the more complex the procedure,
the longer the fluoroscopy time and ESD, with patients undergoing atherec-
tomy (ATH) having significantly higher ESD than all groups (1260
(900,1542); p.001) (mGy) which was approaching the skin injury thresh-
old of 2000 (mGy). When measuring ED, Cerebrovascular intervention
(CVI) and infrarenal aortic aneurysm (IAA) received the highest ED (120
(100,150), 109(85,151); p.001) (mSv) among other groups. When com-
paring different aneurysm repairs, TAA patients underwent a greater number
of CT scans than IAA (7.40.3 vs 5.80.2; P0.004). After tabulating the
cumulative ED including procedure and CT scans, IAA patients had signif-
icantly higher doses of radiation exposure than TAA ( 2175, 1916 .;
P0.004).
Conclusions: With increasing complexity of endovascular interven-
tions, there is increased radiation exposure to all involved with highest doses
coming from those undergoing any aneurysm repair. Future innovations
should concentrate on reducing the risk of radiation exposure to all person-
nel and newer imaging modalities.
Author Disclosures: M. Bannazadeh, None; T.P. Sarac, PeriTec Biosc-
ciences; NIH SBIR; Armed Forces Institutes of Regenerative Medicine;
PeriTec Biosciences; Medtronic; O. Altinel, None; V. Kashyap, None; D.
Clair, CordisCook, Boston Scientific, Medtronic.
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Conflict of Interest Disclosures in Vascular Surgery
Eric Grossman, Peter Angelos, Tina Desai. The University of Chicago
Medical Center, Chicago, IL
Objectives: Technological advances in Vascular Surgery have pro-
duced a complex relationship between pharmaceutical corporations and
surgeons. However, the influence of industry on scientific presentations at
national meetings is not known. This study describes the prevalence and
patterns of reported Conflict of Interest (COI) at the Society of Vascular
Surgery (SVS) annual conference.
Methods: Data from the programs of the annual SVS meetings from
2005 (when COI disclosure was first required) to 2008 were analyzed.
Results: The percentage of authors declaring at least one COI has
changed little: in 2005, 23% of authors declared at least one COI, compared
to 26% in 2008. However, the number of authors disclosing multiple COI
has increased. Of authors disclosing any COI in 2005, nearly half disclosed
only one; in 2008, more than two thirds disclosed multiple (Graph). Of all
scientific papers presented in 2008 at SVS, 21% had at least one author
declaring COI; of note, at the PVSS session featuring young vascular
surgeons, the incidence was nearly double, 41%.
Conclusions: The influence of industry on the SVS conference has
increased in the past four years. The frequency of COI disclosures at the
PVSS session underscores the importance of endovascular innovation in
which young vascular surgeons may be more likely to be involved. It may
also reflect an evolving emphasis on the “business” of medicine, a concept to
which recently trained surgeons have greater exposure. These results support
the establishment of a comprehensive COI management plan to ensure that
the scientific integrity of the SVS is not undermined by COI. Further study
is needed to determine whether surgeons’ relationships with industry affect
surgical decision making or patient care.Author Disclosures: E. Grossman, None; P. Angelos, Ethicon Endosur-
gery; T. Desai, None.
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Suboptimal Medical Management in Vascular Patients
Daniel D Yeh, Omaida Velazquez, Carl Schulman, Ileen Pringle, Eugene
Knight. University of Miami, Miami, FL
Objective: To assess rates of medication compliance in vascular pa-
tients.
Methods: A prospective study of consecutive patients seen in Vascular
Clinic at a busy tertiary academic center. Patients were interviewed via
standardized questionnaire and evaluated co-existing medical conditions
and medication use. Optimal medical therapy was defined as the 2006
AHA/ACC Guidelines for Secondary Prevention for Atherosclerotic Vas-
cular Disease.
Results: 180 patients were seen in various vascular surgery clinics
affiliated in a 4 month period. Co-morbid conditions surveyed included
HTN (n134), DM (n50), CAD (n19), hypercholesterolemia (n84),
and ESRD (n8). 54% of the patients were male. 58% of the patients were
insured, 34% were uninsured. 18% were current smokers, 68% were non-
smokers. We found that 43% of all patients were receiving inadequate
medical therapy for their co-morbid conditions. Uninsured patients were
more likely (56%) than insured patients (34%) to receive inadequate thera-
py.Lack of insurance was a predictor of inadequate treatment of HTN
(OR3.05, C.I. 1.12-8.3, p0.025), hypercholesterolemia (OR4.5, C.I.
1.4-14.3, p0.007), and any disease overall (OR2.4, C.I. 1.2-4.7,
p0.01) (Fig). Overall, males (49%) were more likely than females (36%) to
receive inadequate medical therapy, especially relating to PVD (OR5.25,
C.I. 1.6-17.3, p0.004). The incidence of suboptimal management was
37% for zero to two co-morbid conditions, but increased to 100% for five
co-morbid conditions.
Conclusions: Uninsured patients were more likely to receive inade-
quate medical therapy than their insured counterparts. This survey provides
sobering statistics regarding medical compliance in a real world medical
practice.
Author Disclosures: O. Velazquez, None; C. Schulman, None; I. Prin-
gle, None; E. Knight, None.
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Techniques, Morbidity and Patency of Portal Vein Reconstruction
Using Lower Extremity Vein During Pancreaticoduodenectomy
Erica L Mitchell, Mark A Jones, Gregory J Landry, Timothy K Liem, Brett
C Sheppard, Kevin G Billingsley, Gregory L Moneta. Oregon Health &
Science University, Portland, OR
Background: Tumor invasion or adherence of the pancreas to the
portal vein (PV) complicates pancreaticoduondenectomy. Lower extremity
vein (LEV) can provide autogenous conduits for PV reconstruction in such
cases. Little data exist, however, describing PV reconstruction techniques,
morbidity or patency using LE vein as part of pancreaticoduondenectomy.
Methods: We analyzed preoperative imaging, reconstructive tech-
niques, perioperative morbidity related to LEV vein harvest, and reconstruc-
tion patency in patients undergoing PV reconstruction during pancreati-
coduondenectomy.
Results: Thirty-one of 227 patients (14%) undergoing pancreati-
coduondenectomy had PV reconstruction using LEV. Mean age was 63
years. Preoperative imaging indicated tumor adherence or invasion of the
PV in only 39% of the patients requiring PV reconstruction. Preoperative
vein mapping influenced the choice of LEV used for reconstruction by
identifying abnormalities in 47%. Reconstruction technique (patch vs.
replacement) was determined by extent of PV adherence / invasion. PV
patching using greater saphenous vein (GSV) or femoral vein (FV) was
performed in 19 cases (61%) and PV replacement using FV was required
in 12 cases (39%). Wound complications or ipsilateral DVT occurred in
no patients with GSV harvests and in 38% of patients with FV harvests, p
0.019. Two reoperations were required for wound complications.
There was one intraoperative PV thrombosis requiring revision, one
occlusion in 30 days and 1 known late occlusion secondary to local
disease recurrence. Twelve month patency of PV reconstruction was 96%
with a mean follow-up of 5.4 months.
Conclusions: Preoperative imaging may fail to confirm PV involve-
ment in patients undergoing pancreaticoduodenectomy. Preoperative vein
mapping influences conduit choice in patients requiring PV reconstruction
and should be performed prior to pancreaticoduodenectomy. Minimal
morbidity is associated with GSV harvest while FV harvest is associated with
manageable complications. PV reconstruction with LEV provides excellent
